Elevated risk from estrogens in the Yodo River basin (Japan) in winter and ozonation as a management option

Distribution of Anticancer Drugs in River Waters and Sediments of the Yodo River Basin, Japan

This article reviews the pollution status of anticancer drugs present in the Yodo River basin located in the Kansai district of Japan, covering both the soluble and insoluble (adsorbed on the river sediments and suspended solids) levels. Procedures ranging from sampling in the field and instrumental analytical methods to the data processing for mass balance estimation of the target basin are also described. All anticancer drugs concerned with this article were detected in sewage and river waters, where the presence of bicalutamide (BLT) was identified at considerably high concentrations (maximum 254 ng/L in the main stream, 151 ng/L in tributaries, and 1032 ng/L in sewage treatment plant (STP) effluents). In addition, sorption distribution coefficient (logKd) values showed a tendency to become higher in the silty sediments at Suita Bridge than in the sandy sediments at Hirakata Bridge; these trends were supported by the results of the laboratory-scale sorption experiment. STPs were concluded to be the main sources of the anticancer drug load in the river, and a mass flux evaluation revealed that the effect of attenuation in the river environment was small. The effectiveness of ozonation in the sewage treatment process for removal of these anticancer drugs was further confirmed. The present article should be of value for facilitating the environmental risk assessment of a wide range of drugs in a broader geographical area.

Balancing environmental quality standards and infrastructure upgrade costs for the reduction of microcontaminant loads in rivers

Investments for upgrading wastewater treatment plants (WWTPs) with tertiary treatment to reduce microcontaminant loads in surface waters at a catchment scale can be daunting. These investments are highly sensitive to the selection of environmental quality standards (EQSs) for the target microcontaminants. Our hypothesis is that there is a balance between EQS selection and investment that needs to be considered in decision-making. We used a customized microcontaminant fate and transport model coupled to an optimization algorithm to validate this hypothesis in the Llobregat river basin and for the pharmaceutical compound diclofenac. The algorithm optimizes the number of WWTPs in this catchment requiring an upgrade to minimize the total amount of diclofenac that exceeds the EQS in every river section and the total cost. We simulated and optimized 40 scenarios representing a combination of 4 potential EQSs (10, 30, 50 and 100 ng L^-1), 5 levels of uncertainty bounds in the predictions of river concentrations and 2 hydrological scenarios (average flows, flows annually exceeding 30% of the days; and environmental flows, flows annually exceeding 99% of the days). The results showthat there is a nonlinear relationship between the EQS and the required investment. The investment increases by 100% from an EQS of 100 ng L^-1 to 10 ng L^-1, significantly increasing (by 60%) from 30 to 10 ng L^-1. Thus, establishing an EQS of 30 ng L^-1 would balance environmental protection and costs. The selection of the hydrological conditions also plays a key role in the upgrade analysis because the costs for environmental flows are 50% higher than for average flows. Finally, we highlight that the investment in research would allow the reduction of uncertainties, hence allowing more qualified decisions to be made and a reduction in the WWTP upgrade costs (up to 4 €·household^-1·year^-1).

[Newly Designed Water Treatment Systems for Hospital Effluent]

　Pharmaceuticals are indispensable to contemporary life. Recently, the emerging problem of pharmaceutical-based pollution of river environments, including drinking water sources and lakes, has begun to receive significant attention worldwide. Because pharmaceuticals are designed to perform specific physiological functions in targeted regions of the human body, there is increasing concern regarding their toxic effects, even at low concentrations, on aquatic ecosystems and human health, via residues in drinking water. Pharmaceuticals are consistently employed in hospitals to treat disease; and Japan, one of the most advanced countries in medical treatment, ranks second worldwide in the quantity of pharmaceuticals employed. Therefore, the development of technologies that minimize or lessen the related environmental risks for clinical effluent is an important task as well as that for sewage treatment plants (STPs). However, there has been limited research on clinical effluent, and much remains to be elucidated. In light of this, we are investigating the occurrence of pharmaceuticals, and the development of water treatment systems for clinical effluent. This review discusses the current research on clinical effluent and the development of advanced water treatment systems targeted at hospital effluent, and explores strategies for future environmental risk assessment and risk management.

Modeling the fate and transport of 17β-estradiol in the South River watershed in Virginia

Hormones excreted by livestock metabolisms often enter surface water through feces and urine and can potentially cause adverse impacts to aquatic biota. This study involved a modeling analysis of 17β-estradiol (E2), a prevalent estrogen, in the South River watershed located in Augusta County, Virginia from 2013 to 2015. Cattle manure, poultry litter, biosolids, septic systems, and wastewater treatment plants (WWTPs) were considered as sources of E2 in this study. The EPA's BASINS modeling framework was configured to track the fate and transport of E2. The first-order kinetics and the wash-off model were adopted to characterize the attenuation and the transport of E2. The modeling results indicated that the flow rate was a major input affecting the simulated E2 levels in the water. During storm events, E2 on the land surface was transported into the rivers by the surface runoff and the E2 released into streams was diluted by the high water flow. Variations of the simulated E2 concentrations in the South River depended on the relative magnitudes of the loads from point and nonpoint sources. Modeling results showed that E2 levels in the South River were below the lowest observable effect level (LOEL) for fish. However, the practices of storing manure before land application and fencing off rivers to keep cattle out of the water are encouraged to prevent the potential for high E2 levels in streams receiving feedlot runoff.

Distribution of six anticancer drugs and a variety of other pharmaceuticals, and their sorption onto sediments, in an urban Japanese river

The distributions of 31 pharmaceuticals grouped into nine therapeutic classes, including six anticancer drugs, were investigated in the waters and sediments of an urban river in Japan. The coefficients of sorption (logK _d) to the river sediments were also determined from the results of a field survey and laboratory-scale experiment. Three anticancer drugs-bicalutamide, doxifluridine, and tamoxifen-were detected in the river sediments at maximum concentrations of 391, 392, and 250 ng/kg, respectively. In addition, the transformation products of psychotropic carbamazepine (2-hydroxy carbamazepine, acridine, and acridone) were detected in the range of 108 ng/kg (2-hydroxy carbamazepine) to 2365 ng/kg (acridine), and the phytoestrogen glycitein was detected in the range of N.D. to 821 ng/kg. The logK _d values of the targeted pharmaceuticals in river sediments in the field survey ranged from 0.5 (theophylline) to 3.3 (azithromycin). These results were in accord with those of the laboratory-scale sorption experiment. To the best of our knowledge, this is the first report of the detection of the anticancer drugs bicalutamide and tamoxifen, the transformation products of carbamazepine (2-hydroxy carbamazepine, acridine, and acridone), and the phytoestrogen genistein in river sediments.

Detection of pharmaceuticals and phytochemicals together with their metabolites in hospital effluents in Japan, and their contribution to sewage treatment plant influents

The occurrence of 41 pharmaceuticals and phytochemicals (PPs) including their metabolites was surveyed in hospital effluent in an urban area of Japan. A detailed survey of sewage treatment plant (STP) influent and effluent, and river water was also conducted. Finally, mass balances with mass fluxes of the target PPs through the water flow were evaluated and the degree of contribution of hospital effluent to the environmental discharge was estimated. The results indicate that 38 compounds were detectable in hospital effluent over a wide concentration range from ng/L to μg/L, with a maximum of 92μg/L. The contributions of PPs in the hospital effluent to STP influent varied widely from <0.1% to 14.8%. Although almost all of the remaining components could be removed below 1.0ng/L at STPs by the addition of ozone treatment, a number of PPs still remained above 10ng/L in STP effluent. These findings suggest the importance of applying highly developed treatments to hospital effluents and at STPs in the future to reduce the environmental risks posed by PPs. To our knowledge, this is the first demonstration of the presence of two conjugated metabolites of acetaminophen, acetaminophen glucuronide and acetaminophen sulfate, as well as of loxoprofen and loxoprofen alcohol, in hospital effluent, STP, and river waters.